Cardinal Health's CFO Jorge Gomez will step down from his role Aug. 9 to join Dentsply Sirona, a dental products maker, according to The Wall Street Journal.
Pharmacy
Illinois paid $4.7 million to more than 70 independent pharmacies to help offset inadequate reimbursement from filling prescriptions for Medicaid beneficiaries, according to The State Journal-Register.
Acer Therapeutics, a rare-disease drugmaker, has cut 60 percent of its workforce two weeks after the FDA refused to approve its lead drug candidate Edsivo for a rare connective tissue disorder.
Fresenius Kabi has recalled two lots of its chemotherapy drug fluorouracil after glass particulate was discovered in five vials.
PharMEDium Services is recalling 45 lots of its injectable hydromorphone because they were classified as sulfite-free, but the products contain sulfites.
President Donald Trump said he is preparing an executive order to lower prescription drug prices in the U.S. to the lowest price paid among other developed countries, according to CNBC.
Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety.
Former FDA Commissioner Scott Gottlieb, MD, is defending his decision to join the board of a drug company he once regulated, saying he is "very proud" of his new role at Pfizer, according to CNBC.
Controlling drug spending is top-of-mind for many healthcare leaders, especially as declining reimbursements and increasing drug costs cut into hospital margins.
Pharmaceutical companies have raised the prices of 3,400 drugs this year, 17 percent more than during the same period last year, according to a new Rx Savings Solutions analysis cited by CBS News.